©
Freepik
The research team are using the Data Portal to understand in more detail the natural history of the disease in terms of its genetics in order to: identify clinical endpoints and biomarkers that evolve with disease course in the most predictable fashion in longitudinal studies; define sub-populations of interest for closer study, and estimate the effect of changes to appropriately design clinical studies.